SCHEMBL6344780

SCHEMBL6344780

O=C(O)C1CCC(c2c[nH]c3cc(F)ccc23)CC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.56
DRD2 P14416 4/20 0.54
ADRA1D P25100 3/20 0.52
IDO1 P14902 1/20 0.49
HTR2A P28223 5/20 0.48
HTR7 P34969 3/20 0.48
KCNH2 Q12809 3/20 0.48
HTR1A P08908 2/20 0.47
TDO2 P48775 1/20 0.47
OPRM1 P35372 1/20 0.47
OPRL1 P41146 1/20 0.47
HSD11B1 P28845 1/20 0.46
CCR2 P41597 1/20 0.46
ADRA1B P35368 1/20 0.45
HTR1B P28222 2/20 0.45
HTR1D P28221 1/20 0.45
DRD1 P21728 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6342293 0.89 HSD11B1 (0.58) SLC6A4IDO1HTR2AHTR1AOPRM1
SCHEMBL18324840 0.82 HSD11B1 (0.65) SLC6A4DRD2ADRA1DHTR2AHTR7
SCHEMBL6184605 0.82 DRD2 (0.61) SLC6A4DRD2ADRA1DHTR2AHTR7
SCHEMBL9703341 0.80 HTR2C (0.60) ADRA1DHTR2AHSD11B1CCR2
SCHEMBL6636763 0.79 DRD2 (0.57) SLC6A4DRD2ADRA1DIDO1HTR2A
SCHEMBL30275187 0.79 HTR2A (0.64) SLC6A4DRD2ADRA1DIDO1HTR2A
SCHEMBL2904310 0.79 HTR2A (0.64) SLC6A4DRD2ADRA1DIDO1HTR2A
Formic Acid SCHEMBL27577048 0.78 ADRA1D (0.58) SLC6A4DRD2ADRA1DIDO1HTR2A
SCHEMBL16802074 0.78 KDM4E (0.69) SLC6A4DRD2ADRA1DHTR2AHTR7
SCHEMBL18324842 0.78 DRD2 (0.66) SLC6A4DRD2ADRA1DHTR2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176730-A1 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT 1B/1D ligands MERCK PATENT GMBH (DE) 2005-08-11 US disclosed
US-20030064995-A1 Amide and urea derivatives as 5-HT reuptake inhibitors and as5-HT1B/1D ligands MERCK PATENT GMBH (DE) 2003-04-03 US disclosed
US-6509340-B1 These preparations can be employed as medicaments in human and veterinary medicine. Possible excipients are organic or inorganic substances which are suitable for enteral (e.g. oral) on the central nervous system. MERCK PATENTGESELLSCHAFT (DE) 2003-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176730-A1 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT 1B/1D ligands HTR1B, HTR1D, HTR1A SLC6A4 27/4885DRD2 18/4885ADRA1D 76/4885
US-20030064995-A1 Amide and urea derivatives as 5-HT reuptake inhibitors and as5-HT1B/1D ligands HTR5A, HTR1B, HTR1A SLC6A4 74/4885DRD2 44/4885ADRA1D 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.